Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands

The first [Pd(Lⁿ)₂(ox)] xH₂O oxalato(ox) complexes involving 2-chloro-N6-(benzyl)-9-isopropyladenine (L¹; complex 1), 2-chloro-N6-(4-methoxybenzyl)-9-isopropyladenine (L²; 2), 2-chloro-N6-(2,3-dimethoxybenzyl)-9-isopropyladenine (L³; 3), 2-chloro-N6-(2,4-dimethoxybenzyl)-9-isopropyladenine (L⁴; 4), and 2-chloro-N6-(4-methylbenzyl)-9-isopropyladenine (L⁵; 5) have been synthesized by the reactions of potassium bis(oxalato)palladate(II) dihydrate, [K₂Pd(ox)₂]·2H₂O, with the mentioned organic compounds (H₂ox = oxalic acid; x = 0 for 1-3 and 5 or 2 for 4). Elemental analyses (C, H, N), FTIR, Raman and NMR (¹H, ¹³C, ¹⁵N) spectroscopies, conductivity measurements and thermal studies (thermogravimetric and differential thermal analyses, TG/DTA) have been used to characterize the prepared complexes. The molecular structures of [Pd(L²)₂(ox)] (2) and [Pd(L⁵)₂(ox)]·L⁵·Me₂CO (5·L⁵·Me₂CO) have been determined by a single crystal X-ray analysis. The geometry of these complexes is slightly distorted square-planar with two appropriate Lⁿ (n = 2 or 5) molecules mutually arranged in the head-to-head (2) or head-to-tail (5) orientation. The Lⁿ ligands are coordinated to the central Pd(II) ion via the N7 atoms. The same conclusions regarding the binding properties of L¹-L⁵ ligands can be made based on multinuclear NMR spectra. In vitro cytotoxicity of the complexes 1-5 has been evaluated against human chronic myelogenous leukaemia (K562) and human breast adenocarcinoma (MCF7) cancer cell lines. Significant cytotoxicity has been determined for the complexes 3 (IC₅₀ = 6.2 μM) and 5 (IC₅₀ = 6.8 μM) on the MCF7 cell line, which is even better than that found for the well-known and widely-used platinum-bearing antineoplastic drugs, i.e. oxaliplatin and cisplatin.     

Structural change of supramolecular coordination polymers of itaconic acid and 1,10-phenanthroline along lanthanide series

Five new supramolecular lanthanide coordination polymers with three different structures, {[La₂(IA)₃(phen)₂] · 2H₂O}_n (1), {[Ln(IA)_1.5(phen)] · xH₂O}_n [x = 1, Ln = Eu (2); x = 0.25, Ln = Dy (3)], and [Ln(IA)_1.5(phen)]_n [Ln = Er (4); Yb (5)], were prepared by hydro- and solvothermal reactions of lanthanide chlorides with itaconic acid (H₂IA) and 1,10-phenanthroline (phen), and structurally characterized by single crystal X-ray diffraction. 1 Comprises 1-D double-chains that are further assembled to a 3-D supramolecular structure via hydrogen bonds and π-π stacks between phen molecules. 2 and 3 have 2-D infinite networks which are further constructed to form 3-D supramolecular architectures with 1-D channels by π-π aromatic interactions. 4 and 5 have 2-D layer structures consisting of three types of rings which are further architectured to form 3-D supramolecular structures by C-H?O hydrogen bonds. The H₂IA ligands are all completely deprotonated and exhibit tetra-, penta-, and hexadentate coordination modes in the titled complexes. The high-resolution emission spectrum of 2 shows only one Eu³⁺ ion site in 2, which is in agreement with the result of X-ray diffraction. And the magnetic property and the thermal stability of 2 were also investigated.     

Molecular interactions of zinc(II) cyclams with polycarboxylato ligands

Four new zinc(II) cyclams of the composition {Zn(L)(tp²⁻) · H₂O}_n (1), {Zn(L)(H₂bta²⁻) · 2H₂O}_n (2), [Zn₂(L)₂(ox²⁻)] 2ClO₄ · 2DMF (3), and Zn(L)(H₂btc⁻)₂ · 2DMF (4), where L = cyclam, tp²⁻ = 1,4-benzenedicarboxylate ion, H₂bta²⁻ = 1,2,4,5-benzenetetracarboxylate ion, ox²⁻ = oxalate ion, DMF = N,N-dimethylformamide, and H₂btc⁻ = 1,3,5-benzenetricarboxylate ion, have been synthesized and structurally characterized by a combination of analytical, spectroscopic and crystallographic methods. The carboxylato ligands in the complexes 1-4 show strong coordination tendencies toward zinc(II) cyclams with hydrogen bonding interactions between the pre-organized N-H groups of the macrocycle and oxygen atoms of the carboxylato ligands. The macrocycles in 1, 2, and 4 adopt trans-III configurations with the appropriate R,R,S,S arrangement of the four chiral nitrogen centers, respectively. However, the complex 3 shows an unusual cis V conformation with the R,R,R,R nitrogen configuration. The finding of strong interactions between the carboxylato ligands and the zinc(II) ions may provide additional knowledge for the improved design of receptor-targeted zinc(II) cyclams in anti-HIV agents.     

Assembly of two novel cadmium(II) supramolecular architectures constructed from pyridine-functionalized 1,10-phenanthroline ligand

Two novel cadmium(II) coordination polymers [Cd(pyip)(ox)]·H₂O (1) and [Cd₂(pyip)₂(ox)₂·(H₂O)][Cd(pyip)(ox)]·4(H₂O) (2) (pyip = 2-(pyridin-3-yl-1H-imidazo [4,5-f][1,10]phenanthroline, H₂ox = oxalic acid), have been hydrothermal synthesized and characterized by single crystal X-ray diffraction. Compound 1 is 1D zigzag chain, in which oxalate anion as bridging ligand is responsible for the formation of the main framework and pyip as chelating ligand grafts on two sides of the zigzag chain. Compound 2 contains two kinds of independent polymers [Cd₂(pyip)₂(ox)₂(H₂O)] (A) and [Cd(pyip)(ox)] (B) to form an interdigitated 1D + 1D structure, in which polymers A and B are paratactically assembled in an ABCD sequence. The fundamental unit of polymer B in 2 is the same as that in 1. For compounds 1-2, weak interactions, primarily hydrogen bonding and π?π stacking interactions, have greatly influence on the supramolecular motifs recognized in the crystal packing. Especially, the oxalate anions as bridging ligand simultaneously adopt multiform coordination modes in two compounds. In addition, 1 and 2 displayed a strong fluorescent emission in the solid state at room temperature.     

Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: Synthesis, general properties, H, C and N{H} NMR characterization and in vitro cytotoxicity

Reactions of potassium bis(oxalato)palladate dihydrate, K₂[Pd(ox)₂]·2H₂O, with two molar equivalents of N6-(benzyl)-9-isopropyladenine-based organic molecules (L_1-7), i.e. 2-chloro-N6-(2-methoxybenzyl)-9-isopropyladenine (L₁), 2-chloro-N6-(3-methoxybenzyl)-9-isopropyladenine (L₂), 2-chloro-N6-(3,5-dimethoxybenzyl)-9-isopropyladenine (L₃), 2-(1-ethyl-2-hydroxyethylamino)-N6-(benzyl)-9-isopropyladenine (L₄), 2-(1-ethyl-2-hydroxyethylamino)-N6-(2-methoxybenzyl)-9-isopropyladenine (L₅), 2-(1-ethyl-2-hydroxyethylamino)-N6-(3-methoxybenzyl)-9-isopropyladenine (L₆) and 2-(1-ethyl-2-hydroxyethylamino)-N6-(4-methoxybenzyl)-9-isopropyladenine (L₇), provided a series of seven palladium(II) oxalato (ox) complexes of the general formula [Pd(ox)(L_1-7)₂]·nH₂O (1-7; n = 0 for 4, 5 and 7, ¾ for 1 and 2, 1 for 6, and 3 for 3). The compounds were characterized by elemental analysis, IR, Raman, ¹H, ¹³C and ¹⁵N{¹H} NMR spectroscopy, ESI+ mass spectrometry, molar conductivity and TG/DTA thermal analysis. The geometry of [Pd(ox)(L₂)₂] (2) was optimized on the B3LYP/6-311G∗/LANL2DZ level of theory. The complexes 4-7 represent the first palladium(II) oxalato complexes with a PdN₂O₂ donor set, which involve highly potent purine-based cyclin-dependent kinase (CDK) inhibitors (L_4-7) as carrier N-donor ligands. The selected complexes 1, 3-5 and 7 were tested by an MTT assay for their in vitro cytotoxic activity against human osteosarcoma (HOS) cancer cell line. The highest activity was found for the complexes 5 (IC₅₀ = 34.9 μM) and 7 (IC₅₀ = 39.2 μM).     

Synthesis, structures and DNA binding of ternary transition metal complexes M(II)L with the 2,2-bipyridylamine (L = p-HB, M = Co, Ni, Cu and Zn)

New ternary transition metal complexes of formulations [Co(bpa)(p-HB)₂](bpa = 2,2′-bipyridylamine, p-HB = p-hydroxybenzenecarboxylic acid) (1), [Ni(bpa)(p-HB)(H₂O)₂]⁺(NO₃)⁻ · H₂O (2), , [Cu(bpa)(p-HB)Cl] (4) and [Zn(bpa)(p-HB)₂]₂ · 0.5H₂O (5) are prepared, their structural features are characterized by crystal structural studies, and their DNA binding propensity has been evaluated by fluorescence method. The molecular structure of complex 1 shows the six coordinate octahedral geometry with one bpa and two p-HB ligands, complex 2 is the cationic complex and has the six coordinate octahedral structure with one bpa, one p-HB and two aqua ligands, complex 3 is also the cationic complex of octahedral coordination with two bpa and one p-HB ligands, complex 4 is five coordinate distorted square pyramidal with one bpa, one p-HB and chloride ligands and complex 5 has the distorted octahedral coordination with two p-HB and one bpa ligands. In all of the complexes, both bpa and p-HB act as the bidentate N and O-donor ligands, respectively. The intermolecular H-bond networks, together with π-π interaction in their solid state are also described. The complexes show the competitive inhibition of ethidium binding to DNA, and the DNA binding propensity can be reflected as the relative order: 3 > 2 > 1 > 5 > 4, in which the cationic charged Ni(II) complexes 2 and 3 show the most effective inhibition ability.     

Copper(II) complexes with monocarboxylate ligands bearing different substituent groups: Synthesis and spectroscopic studies

In our continuing efforts to explore the effects of substituent groups of ligands in the formation of supramolecular coordination structures, seven new Cu^II complexes formulated as [Cu₂(L¹)₄(DMF)₂] (1), {[Cu₂(L¹)₄(Hmta)](H₂O)_0.75}_∞ (2), [Cu₂(L²)₄(2,2′-bipy)₂] (3), [Cu₂(L³)₄(H₂O)₂] (4), [Cu₂(L³)₄(Hmta)]_∞ (5), [Cu₂(L³)₄(Dabco)]_∞ (6) and [Cu₂(L³)₄(Pz)]_∞ (7) with three monocarboxylate ligands bearing different substituent groups HL¹-HL³ (HL¹ = phenanthrene-9-carboxylic acid, HL² = 2-phenylquinoline-4-carboxylic acid, HL³ = adamantane-1-carboxylic acid, Hmta = hexamethylenetetramine, 2,2′-bipy = 2,2′-bipyridine, Dabco = 1,4-diazabicyclo[2.2.2] octane and Pz = pyrazine), have been prepared and characterized by X-ray diffraction. In 1, 2 and 4-7, each Cu^II ion is octahedrally coordinated, and carboxylate acid acts as a syn-syn bridging bidentate ligand. While each Cu^II ion in 3 is penta-coordinated in a distorted square-pyramidal geometry. 1 and 4 both show a dinuclear paddle-wheel block, while 2, 5, 6 and 7 all exhibit an alternated 1D chain structure between dinuclear paddle-wheel units of the tetracarboxylate type Cu₂-(RCO₂)₄ and the bridging auxiliary ligands Hmta, Dabco and Pz. Furthermore, 3 has a carboxylic unidentate and μ_1,1-oxo bridging dinuclear structure with the chelating auxiliary ligand 2,2′-bipy. Moreover, complexes 1-6 were characterized by electron paramagnetic resonance (EPR) spectroscopy.     

Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity

[Pt(L)₂(ox)] (1), [Pt(2-OMeL)₂(ox)] (2), [Pt(3-OMeL)₂(ox)] (3), [Pt(2,3-diOMeL)₂(ox)] (4), [Pt(2,4-diOMeL)₂(ox)] (5), [Pt(3,4-diOMeL)₂(ox)] (6) and [Pt(3,5-diOMeL)₂(ox)]·4H₂O (7) platinum(II) oxalato (ox) complexes were synthesized using the reaction of potassium bis(oxalato)platinate(II) dihydrate with 2-chloro-N6-(benzyl)-9-isopropyladenine or its benzyl-substituted analogues (nL). The complexes 1-7, which represent the first platinum(II) oxalato complexes involving adenine-based ligands, were fully characterized by various physical methods including multinuclear and two dimensional NMR spectroscopy. A single-crystal X-ray analysis of [Pt(2,4-diOMeL)₂(ox)]·2DMF (5·2DMF; DMF = N,N′-dimethylformamide), proved the slightly distorted square-planar geometry in the vicinity of the Pt(II) ion with one bidentate-coordinated oxalate dianion and two adenine derivatives (nL) coordinated to the Pt(II) centre through the N7 atom of an adenine moiety, thereby giving a PtN₂O₂ donor set. In vitro cytotoxicity of the prepared complexes was tested by an MTT assay against osteosarcoma (HOS) and breast adenocarcinoma (MCF7) human cancer cell lines. The best results were achieved for the complexes 2 and 5 in the case of both cell lines, whose IC₅₀ values equalled 3.6 ± 1.0, and 4.3 ± 2.1 μM (for 2), and 5.4 ± 3.8, and 3.6 ± 2.1 μM (for 5), respectively. The IC₅₀ equals 9.2 ± 1.5 μM against MCF7 cells in the case of 1. The in vitro cytotoxicity of the mentioned complexes significantly exceeded commercially used platinum-based anticancer drugs cisplatin (34.2 ± 6.4 μM and 19.6 ± 4.3 μM) and oxaliplatin (> 50.0 μM for both cancer cell lines).     

Novel topological nets of lanthanide metal-organic frameworks based on dicarboxylate ligands

Four novel topological nets of lanthanide metal-organic frameworks: [Sm₂(op)₃(H₂O)]_n (1), {Ln₂(op)₂(ox)(H₂O)₄] · H₂O}_n (Ln = La, 2; Sm, 3), {[La₂(mp)₂(ox)(H₂O)₄] · 2H₂O}_n (4), [La₂(op)₂(mp)(H₂O)₄]_n (5) (op = o-phthalate, mp = m-phthalate, and ox = oxalate), have been hydrothermally synthesized and characterized. Compound 1 exhibits novel (3,4,5,6)-connected five-nodal two-dimensional net, compound 2 and 3 show the (3,4)-connected V₂O₅ topologies, compound 4 has the (4,5)-connected topological net, and compound 5 shows the (4,5)-connected four-nodal three-dimensional network. Photoluminescent analyses of 1 and 3 show strong blue emission in the solid state at room temperature.     

Oxime-functionalized diazamesocyclic derivates and their metal complexes: Effect of the ligand backbones and anions on the generation of novel monomeric and mono-μ-Cl dimeric Cu complexes

Two oxime-functionalized diazamesocyclic derivates, namely, N,N′-bis(acetophenoneoxime)-1,4-diazacycloheptane (H₂L¹) and N,N′-bis(acetophenonoxime)-1,5-diazacyclooctane (H₂L²), have been prepared and characterized. Both ligands (obtained in the hydrochloride form) can form stable metal complexes with Cu^II and Ni^II salts, the crystal structures of which were determined by X-ray diffraction technique. The reactions of H₂L¹ with Cu(ClO₄)₂ and Ni(ClO₄)₂ afford a penta-coordinated mononuclear complex [Cu(H₂L¹)Cl] · ClO₄ (1) and a four-coordinated monomeric [Ni(HL¹)] · ClO₄ (2), in which the ligand is monodeprotonated. The ligand H₂L² also forms a quite similar mononuclear [Ni(HL²)] · ClO₄ complex with Ni(ClO₄)₂, according to our previous work. However, reactions of different Cu^II salts [Cu(ClO₄)₂, CuCl₂ and Cu(NO₃)₂ for 3, and CuSO₄ for 4] with H₂L² in the presence of NaClO₄ yield two unusual mono-μ-Cl dinuclear Cu^II complexes [Cu₂(HL²)₂Cl] · (ClO₄) (3), and [Cu₂(H₂L²)(HL²)Cl] · (ClO₄)₂ · (H₂O)(4). These results indicate that the resultant Cu^II complexes (1, 3 and 4) are sensitive to the backbones of diazamesocycles and even auxiliary anions.     

Syntheses and characterization of five d coordination polymers derived from phenanthroline derivative and dicarboxylate mixed ligands

Five structurally diverse complexes, [Cd₂(pyip)₂(suc)₂]_n·1.5nH₂O (1), [Zn(pyip)(glu)]_n (2), [Cd(pyip)(glu)]_n (3), [Zn(pyip)₂(adip)₂]_n·2.5nH₂O (4), [Cd₃(pyip)₂(adip)₃]_n (5) (pyip = 2-(pyridin-3-yl)-1H-imidazo[4,5-f][1,10]phenan-throline, H₂suc = succinic acid, H₂glu = glutaric acid, H₂adip = adipic acid), have been hydrothermally synthesized. Complexes 1 and 4 are ribbon-like chains, in which pyip ligands attach to the both sides of the chain in pairs. Complex 2 is a one dimensional (1D) wave-like chain, while the pyip ligands attach to only one side of the chain. Complexes 3 and 5 are both two dimensional (2D) networks, in which the dicarboxylate ligands connect the dinuclear or trinuclear Cd^II units into layers with (4, 4) topological network. The structural differences among these complexes show that the organic acids have important influences on the final structures.     

New amino-dithiaphospholanes and phosphoramidodithioites and their rhodium and iridium complexes

New sulfur derivatives of phosphoramidite ligands were synthesized and the impact of the sulfur unit on the spectroscopic properties of their rhodium and iridium complexes was investigated. The new ligands Bn₂NPSCH₂CH₂S^a(P-S^a) (Bn = benzyl, 4), Bn₂NPSCHCHS^a(CH₂)₃C^aH₂(P-S^a)(C^a-S^a) (6) and Bn₂NP(4-XC₆H₄OMe)₂ (X = S, 7a; X = O, 7b) were converted to the rhodium and iridium complexes trans-[Rh(CO)Cl(L)₂] (L = 4, 6, 7), [RhCl(COD)(L)] (L = 4, 6, 7), [IrCl(COD)(7a)] and [IrCl₂Cp∗(6)]. For comparison, some phosphoramidite complexes of these formulations also were synthesized. The new metal complexes were spectroscopically analyzed. For the carbonyl complexes, the ν_CO IR stretching frequencies were lower than for the corresponding phosphite and phosphoramidite ligands. The ¹J_PRh coupling constants for the rhodium complexes with the new ligands were also smaller than for the respective phosphoramidite and phosphite complexes. Finally, the ¹J_PSe coupling constants of the selenides of the new ligands were lower than those of the phosphoramidite ligands but higher than for PPh₃. The spectroscopic data reveal that the new thio ligands 4, 6 and 7a are more electron donating than phosphites and phosphoramidites but less electron donating than PPh₃.     

Syntheses, structures, and magnetic properties of 3d-4f heterometallic complexes constructed from pyrazole-bridged CuLn dinuclear units

A series of pyrazole-bridged heterometallic 3d-4f complexes, [CuDy(ipdc)₂(H₂O)₄] · (2H₂O)(H₃O⁺) (1) and [CuLn(pdc)(ipdc)(H₂O)₄] · H₃O⁺ (Ln = Ho (2), Er (3), Yb (4); H₃ipdc = 4-iodo-3,5-pyrazoledicarboxylic acid; H₃pdc = 3,5-pyrazoledicarboxylic acid), {[Cu₃Ln₄(ipdc)₆(H₂O)₁₆] · xH₂O}_n (Ln = Sm (5), x = 8.5; Ln = Eu (6), x = 7; Ln = Gd (7), Tb (8), x = 9), have been synthesized and structurally characterized. Ligand H₃ipdc was in situ obtained by iodination of ligand H₃pdc. Complexes 1-4 are pyrazole-bridged heterometallic dinuclear complexes, and 2-4 are isostructural. Complexes 5-8 are isostructural and comprised of an unusual infinite one-dimensional tape-like chain based on pyrazole-bridged heterometallic dinuclear units. The magnetic properties of compounds 1-4, 7 and 8 have been investigated through the magnetic measurement over the temperature range of 1.8-300 K.     

3D hydrogen bonded heteronuclear Co, Ni, Cu and Zn aqua complexes derived from dipicolinic acid

The heteronuclear water-soluble and air-stable compounds [M(H₂O)₅M′(dipic)₂] · mH₂O (M/M′ = Cu^II/Co^II (1), Cu^II/Ni^II (2), Cu^II/Zn^II (3), Zn^II/Co^II (4), Ni^II/Co^II (5), m = 2-3; H₂dipic = dipicolinic acid) have been prepared by self-assembly synthesis in aqueous solution at room temperature, and characterized by IR, UV-Vis and atomic absorption spectroscopies, elemental and X-ray diffraction single crystal (for 1 and 2) analyses. 1-5 represent the first examples of heteronuclear dipicolinate compounds with 3d metals. Extensive H-bonding interactions involving all aqua ligands, dipicolinate oxygens and lattice water molecules further stabilize the dimetallic units by linking them to form three-dimensional polymeric networks.     

Hydrogen-bonded copper(II) and nickel(II) complexes and coordination polymeric structures containing reduced Schiff base ligands

Complexes [Cu(HSas)(H₂O)] · 2H₂O (H₃Sas = N-(2-hydroxybenzyl)-l-aspartic acid) (1), [Cu(HMeSglu)(H₂O)] · 2H₂O (H₃MeSglu = (N-(2-hydroxy-5-methylbenzyl)-l-glutamic acid) (2), [Cu₂(Smet)₂] (H₂Smet = (N-(2-hydroxybenzyl)-l-methionine) (3), [Ni(HSas)(H₂O)] (4), [Ni₂(Smet)₂(H₂O)₂] (5), and [Ni(HSapg)₂] (H₂Sapg = (N-(2-hydroxybenzyl)-l-aspargine) (6) have been synthesized and characterized by chemical and spectroscopic methods. Structural determination by single crystal X-ray diffraction studies revealed 1D coordination polymeric structures in 2 and 4, and hydrogen-bonded network structure in 5 and 6. In contrast to previously reported coordination compounds with similar ligands, the phenol remains protonated and bonded to the metal ions in 2 and 4, and also probably in 1. However, the phenolic group is non-bonded in 6.     

Cobalt and cadmium complexes with N-heterocyclic dicarboxylic acid ligands: Syntheses, structures, magnetic and fluorescent properties

Two new complexes, [Co(Himdc)₂(H₂O)₂] (1) and {[Cd(pzdc)(H₂O)]·H₂O}_n (2) (H₂imdc = imidazole-4, 5-dicarboxylic acid, H₂pzdc = pyrazine-2, 3-dicarboxylic acid), have been synthesized and structurally characterized. Compound 1 is a new triclinic mononuclear complex formed by two Himdc⁻ ligands trans coordinated to the Co^II center in bidentate chelate mode and two water ligands. Compound 2 shows a two dimensional layer structure in which pzdc²⁻ dianion ligand adopts unique doubly bridging bis-bidentate μ₄ coordination mode. Temperature-dependent magnetic susceptibilities and thermal stability for 1 and solid-state fluorescent properties for 2 have been discussed in detail.     

Functional mimics of catechol oxidase by mononuclear copper complexes of sterically demanding [NNO] ligands

Several mononuclear copper complexes 1(a-b) and 2(a-b) supported over sterically demanding [NNO] ligands namely, N-(aryl)-2-[(pyridin-2-ylmethyl)amino]acetamide [aryl = 2,6-diethylphenyl (1) and mesityl (2)], exhibit catecholase-like activity in performing the aerial oxidation of 3,5-di-t-butylcatehol (3,5-DTBC) to 3,5-di-t-butyl-catequinone (3,5-DTBQ) under ambient conditions. The 1(a-b) and 2(a-b) complexes were directly synthesized from the reaction of the respective ligands 1-2 with CuX₂·nH₂O (X = Cl, NO₃, n = 2, 3) in 55-85% yield. Mechanistic insights on the catalytic cycle as obtained by density functional theory studies for a representative complex 1a suggest that an intramolecular hydrogen transfer, from a catechol-OH moiety to a copper bound superoxo moiety, form the rate-determining step of the oxidation process, displaying an activation barrier of 18.3 kcal/mol (ΔG^‡) [6.9 kcal/mol in Δ(PE + ZPE)^‡ scale].     

Synthesis and structure of dichloropalladium(II) complexes of heteroleptic N,S- and N,Se-donor ligands based on the 2-organochalcogenomethylpyridine motif, and Mizoroki-Heck catalysis mediated by complexes of N,S-donor ligands

Ligands containing the 2-organochalcogenomethylpyridine motif with substituents in the 4- or 6-position of the pyridyl ring, R⁴,R⁶-pyCH₂ER¹ [R⁴ = R⁶ = H, ER¹ = SMe (1), SeMe (2), SPh (6), SePh (7); R⁴ = Me, R⁶ = H, ER¹ = SMe (3), SPh (8), SePh (9); R⁴ = H, R⁶ = Me, ER¹ = SMe (4), SPh (10), SePh (11); R⁴ = H, R⁶ = Ph, ER¹ = SMe (5), SPh (12), SePh (13)] are obtained on the reaction of R⁴,R⁶-pyMe with LiBuⁿ followed by R¹EER¹. On reaction with PdCl₂(NCMe)₂, the ligands with a 6-phenyl substituent form cyclopalladated species PdCl{6-(o-C₆H₄)pyCH₂ER¹-C,N,E} (5a, 12a, 13a) with the structure of 13a (ER¹ = SePh) confirmed by X-ray crystallography; other ligands form complexes of stoichiometry PdCl₂(R⁴,R⁶-pyCH₂ER¹). Complexes with R⁶ = H are monomeric with N,E-bidentate configurations, confirmed by structural analysis for 3a (R⁴ = Me, ER¹ = SMe), 7a (R⁴ = H, ER¹ = SePh) and 9a (R⁴ = Me, ER¹ = SePh). Two of the 6-methyl substituted complexes examined by X-ray crystallography are oligomeric with trans-PdCl₂(N,E) motifs and bridging ligands, trimeric [PdCl₂(μ-6-MepyCH₂SPh-N,S)]₃ (10a) and dimeric [PdCl₂(μ-6-MepyCH₂SePh-N,Se)]₂ (11a). This behaviour is attributed to avoidance of the Me···Cl interaction that would occur in the cis-bidentate configuration if the pyridyl plane had the same orientation with respect to the coordination plane as observed for 3a, 7a and 9a [dihedral angles 8.0(2)-16.8(2)°]. When examined as precatalysts for the Mizoroki-Heck reaction of n-butyl acrylate with aryl halides in N,N-dimethylacetamide at 120 °C, the complexes exhibit the anticipated trends in yield (ArI > ArBr > ArCl, higher yield for electron withdrawing substituents in 4-RC₆H₄Br and 4-RC₆H₄Cl). The most active precatalysts are PdCl₂(R⁴-pyCH₂SMe-N,S) (R = H (1a), Me (3a)); complexes of the selenium containing ligands exhibit very low activity. For closely related ligands, the changes SMe to SPh, 6-H to 6-Me, and 6-H to 6-Ph lead to lower activity, consistent with involvement of both the pyridyl and chalcogen donors in reactions involving aryl bromides. The precatalyst PdCl₂(pyCH₂SMe-N,S) (1a) exhibits higher activity for the reaction of aryl chlorides in Buⁿ₄NCl at 120 °C as a solvent under non-aqueous ionic liquid (NAIL) conditions.     

Novel 1-D double chain lanthanide complexes: Synthesis, structure and luminescence

Treatment of Ln(NO₃)₃ · 6H₂O with 1, 2-phenylenedioxydiacetic acid (H₂PDOA) in ethanol leads to the unusual 1-D double chain complexes {[Ln(PDOA)_1.5 (H₂O)₃] · H₂O}_n (Ln = Sm (1), Eu (2), Dy (3)), in which the Ln³⁺ ions are linked by pentadentate and bideatate PDOA ligands in two different directions. The chain looks like a ladder containing two -Ln-O-C-O-Ln- chains and PDOA spacers, which has never been observed in the lanthanide carboxylate complexes, and they exhibit different photoluminescence properties.     

Syntheses, crystal structures, and luminescence properties of lanthanide complexes with 5-carboxy-1-carboxymethyl-2-oxidopyridinium

Five new lanthanide complexes Ln(HL)₃(H₂O)₅ · 3H₂O (H₂L = 5-carboxy-1-carboxymethyl-2-oxidopyridinium, Ln = La (1), Sm (2), Eu (3),Tb (4), Dy (5)) have been synthesized and characterized by elemental analyses, FT-IR spectra and X-ray single crystal diffraction. All crystals are isostructural and crystallize in the triclinic space group . The metal center is nine-coordinated completely by two phenol O atoms, two chelating carboxylic O atoms from three HL ligands and five water molecules with a distorted tri-capped trigonal prismatic geometry. Photoluminescence studies revealed that complexes 2-4 exhibit strong fluorescent emission bands in the solid state at room temperature. The transition intensity varies in the order of Tb³⁺ > Dy³⁺ > Eu³⁺ > Sm³⁺.